Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
grade D 34.53 0.06% 0.02
PFE closed up 2.28 percent on Thursday, July 2, 2020, on 1.46 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical PFE trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.06%
Crossed Above 20 DMA Bullish 0.06%
New Uptrend Bullish 0.06%
Pocket Pivot Bullish Swing Setup 0.06%
Calm After Storm Range Contraction 0.06%
Up 3 Days in a Row Strength 0.06%
Up 4 Days in a Row Strength 0.06%
20 DMA Resistance Bearish 2.34%
1,2,3 Retracement Bearish Bearish Swing Setup 2.34%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.34%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.
Biopharmaceutical Health Pharmaceutical Industry Pain Disease Medication Pharmaceutical Products Inflammation Alzheimer's Disease Neuroscience Pain Management Cnx Nifty Dietary Supplements Pulmonary Arterial Hypertension Major Depressive Disorder Hemophilia Anti Infectives Pfizer Erectile Dysfunction Glaxosmithkline Livestock Producers Cardiovascular Endocrine Disorders Lupin Limited Non Pharmaceutical Products

Is PFE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 44.1
52 Week Low 27.88
Average Volume 29,320,889
200-Day Moving Average 36.40
50-Day Moving Average 35.99
20-Day Moving Average 33.74
10-Day Moving Average 32.94
Average True Range 0.91
ADX 29.61
+DI 26.71
-DI 25.38
Chandelier Exit (Long, 3 ATRs ) 33.94
Chandelier Exit (Short, 3 ATRs ) 34.33
Upper Bollinger Band 36.44
Lower Bollinger Band 31.05
Percent B (%b) 0.64
BandWidth 15.98
MACD Line -0.78
MACD Signal Line -0.96
MACD Histogram 0.1803
Fundamentals Value
Market Cap 205.25 Billion
Num Shares 5.95 Billion
EPS 1.37
Price-to-Earnings (P/E) Ratio 25.19
Price-to-Sales 4.06
Price-to-Book 3.64
PEG Ratio 2.40
Dividend 1.28
Dividend Yield 3.71%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.73
Resistance 3 (R3) 35.70 35.28 35.52
Resistance 2 (R2) 35.28 34.97 35.29 35.45
Resistance 1 (R1) 34.89 34.78 34.68 34.92 35.39
Pivot Point 34.47 34.47 34.36 34.48 34.47
Support 1 (S1) 34.08 34.16 33.87 34.11 33.63
Support 2 (S2) 33.66 33.97 33.67 33.57
Support 3 (S3) 33.27 33.66 33.50
Support 4 (S4) 33.30